Homoarginine, kidney function and cardiovascular mortality risk

Nephrology Dialysis Transplantation

Volumn 29, Issue 3, 2014, Pages 663-671

  Tomaschitz, Andreas ^a,b   Meinitzer, Andreas ^a   Pilz, Stefan ^a,c   Rus Machan, Jutta ^b   Genser, Bernd ^d   Drechsler, Christiane ^e   Grammer, Tanja ^d   Krane, Vera ^e   Ritz, Eberhard ^f   Kleber, Marcus E ^d   Pieske, Burkert ^a   Kraigher Krainer, Elisabeth ^a   Fahrleitner Pammer, Astrid ^a   Wanner, Christoph ^e   Boehm, Bernhard O ^g   März, Winfried ^a,d,h  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Specialist Clinic for Rehabilitation PV Bad Aussee   (Austria)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g UNIVERSITY OF ULM   (Germany)

^h SYNLAB ACADEMY   (Germany)

Author keywords

Cardiovascular mortality; Homoarginine; Kidney function

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOARGININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART FAILURE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PATIENT REFERRAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD; COMPLICATION; KIDNEY DISEASE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HOMOARGININE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84895754541     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft512     Document Type: Article

References (38)

1. Bell EA. The isolation of L-homoarginine from seeds of Lathyrus cicera. Biochem J 1962; 85: 91-93
2. Rao SL, Ramachandran LK, Adiga PR. The isolation and characterization of L-homoarginine from seeds of Lathyrus sativus. Biochemistry 1963; 2: 298-300
3. Angkanaporn K, Ravindran V, Bryden WL. Additivity of apparent and true ileal amino acid digestibilities in soybean meal, sunflower meal, and meat and bone meal for broilers. Poult Sci 1996; 75: 1098-1103
4. Henningsson R, Lundquist I. Arginine-induced insulin release is decreased and glucagon increased in parallel with islet NO production. Am J Physiol 1998; 275: E500-E506
5. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990; 87: 5193-5197
6. van der Zwan LP, Davids M, Scheffer PG et al. L-Homoarginine and L-arginine are antagonistically related to blood pressure in an elderly population: the Hoorn study. J Hypertens 2013; 31: 1114-1123
7. Valtonen P, Laitinen T, Lyyra-Laitinen T et al. Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flowmediated vasodilatation. Circ J 2008; 72: 1879-1884
8. März W, Meinitzer A, Drechsler C et al. Homoarginine, cardiovascular risk, and mortality. Circulation 2010; 122: 967-975
9. Pilz S, Meinitzer A, Tomaschitz A et al. Low homoarginine concentration is a novel risk factor for heart disease. Heart 2011; 97: 1222-1227
10. Pilz S, Tomaschitz A, Meinitzer A et al. Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography. Stroke 2011; 42: 1132-1134
11. Ryan WL, Wells IC. Homocitrulline and homoarginine synthesis from lysine. Science 1964; 144: 1122-1127
12. Levillain O, Marescau B, Possemiers I et al. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study. Pflugers Arch 2001; 442: 558-569
13. Al Banchaabouchi M, Marescau B, Van Marck E et al. Long-term effect of partial nephrectomy on biological parameters, kidney histology, and guanidino compound levels in mice. Metabolism 2001; 50: 1418-1425
14. Levillain O, Marescau B, de Deyn PP. Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy. Kidney Int 1995; 47: 464-472
15. Tonelli M, Wiebe N, Culleton B et al. Chronic kidney disease and mortality risk: a systematic review. JASN 2006; 17: 2034-2047
16. Drechsler C, Meinitzer A, Pilz S et al. Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients. Eur J Heart Fail 2011; 13: 852-859
17. Ravani P, Maas R, Malberti F et al. Homoarginine and mortality in predialysis chronic kidney disease (CKD) patients. PLoS One 2013; 8: e72694
18. Winkelmann BR, März W, Boehm BO et al. Rationale and design of the LURIC study - a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001; 2 (Suppl 1): S1-73
19. International Expert C. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334
20. Zipes DP, Camm AJ, Borggrefe M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 2006; 27: 2099-2140
21. Chugh SS, Jui J, Gunson K et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol 2004; 44: 1268-1275
22. Deyl Z, Hyanek J, Horakova M. Profiling of amino acids in body fluids and tissues by means of liquid chromatography. J Chromatogr 1986; 379: 177-250
23. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003; 18: 2024-2031
24. Stevens LA, Coresh J, Schmid CH et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: 395-406
25. Ryan WL, Barak AJ, Johnson RJ. Lysine, homocitrulline, and homoarginine metabolism by the isolated perfused rat liver. Arch Biochem Biophys 1968; 123: 294-297
26. Ryan WL, Johnson RJ, Dimari S. Homoarginine synthesis by rat kidney. Arch Biochem Biophys 1969; 131: 521-526
27. Davids M, Ndika JD, Salomons GS et al. Promiscuous activity of arginine: glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginine. FEBS Lett 2012; 586: 3653-3657
28. Kleber ME, Seppala I, Pilz S et al. Genome-wide association study identifies 3 genomic loci significantly associated with serum levels of homoarginine: the AtheroRemo Consortium. Circ Cardiovasc Genet 2013; 6: 505-513
29. Tofuku Y, Muramoto H, Kuroda M et al. Impaired metabolism of guanidine acetic acid in uremia. Nephron 1985; 41: 174-178
30. Chambers JC, Zhang W, Lord GM et al. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 2010; 42: 373-375
31. Kottgen A, Glazer NL, Dehghan A et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009; 41: 712-717
32. Drechsler C, Kollerits B, Meinitzer A et al. Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study. PLoS One 2013; 8: e63560
33. Kato T, Sano M. Effect of ammonium chloride on homocitrulline and homoarginine synthesis from lysine. J Inherit Metab Dis 1993; 16: 906-907
34. Kato T, Sano M, Mizutani N. Homocitrullinuria and homoargininuria in lysinuric protein intolerance. J Inherit Metab Dis 1989; 12: 157-161
35. de Jonge WJ, Marescau B, D'Hooge R et al. Overexpression of arginase alters circulating and tissue amino acids and guanidino compounds and affects neuromotor behavior in mice. J Nutr 2001; 131: 2732-2740
36. Cullen ME, Yuen AH, Felkin LE et al. Myocardial expression of the arginine: glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation 2006; 114(1 Suppl): I16-I20
37. Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev 2000; 80: 1107-1213
38. Taes YE, Marescau B, De Vriese A et al. Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrol Dial Transplant 2008; 23: 1330-1335